Evolving European guidance on the medical management of neovascular age related macular degeneration.

Journal article

BACKGROUND: Until recently, only two options were available for the treatment of choroidal neovascularisation (CNV) associated with age related macular degeneration (AMD)-thermal laser photocoagulation and photodynamic therapy with verteporfin (PDT-V). However, new treatments for CNV are in development, and data from phase III clinical trials of some of these pharmacological interventions are now available. In light of these new data, expert guidance is required to enable retina specialists ...

Expand abstract

Authors: Chakravarthy, U; Soubrane, G; Bandello, F; Chong, V; Creuzot-Garcher, C

• Journal: British journal of ophthalmology
• Volume: 90
• Issue: 9
• Pages: 1188-1196
• Publication date: 2006-09-01
• DOI: 10.1136/bjo.2005.082255
• EISSN: 1468-2079
• ISSN: 0007-1161
• Language: English
• Keywords: Treatment Outcome; Humans; Triamcinolone Acetonide; Aptamers, Nucleotide; Evidence-Based Medicine; Pregnadienediols; Macular Degeneration; Antibodies, Monoclonal, Humanized; Photochemotherapy; Choroidal Neovascularization; Antibodies, Monoclonal